Small Study Evaluates Same‐Day Discharge After Peripheral Artery Interventions
April 12, 2018—In Catheterization and Cardiovascular Interventions, Ashequl M. Islam, MD, et al published findings from a randomized controlled study to assess the feasibility, safety, and patient satisfaction of same‐day discharge after peripheral artery interventions.
The background of the study is that although diagnostic angiography is routinely performed as a same‐day procedure, same‐day percutaneous transluminal angioplasty is less common. Because there is a very low incidence of periprocedural complications after 4 hours, discharge after this window is possible provided the patient is able to ambulate and has necessary social support. Safety and patient satisfaction related to same‐day discharge have not been systematically studied in this population, noted the investigators.
As summarized in Catheterization and Cardiovascular Interventions, patients undergoing outpatient peripheral artery interventions at a single institution between 2011 and 2015 were randomized to usual care (overnight stay) or same-day discharge after successful interventions. Patient satisfaction, complications, and readmission status were ascertained by blinded telephone interviewers between 48 and 72 hours and 10 days postprocedure.
A total of 24 patients consented to participating in the study. Of these patients, five (21.7%) failed screening, leaving 19 patients for randomization to control (n = 10) and experimental group (n = 9) conditions. The same-day discharge group experienced zero complications; however, their Likert scale scores were significantly lower than overnight stay for the perceived level of safety (P = .02) and the likelihood of having the procedure again (P = .004).
This small, single‐center randomized study found that among carefully selected peripheral artery interventions, same-day discharge may be feasible and safe. However, patient satisfaction and perceived safety were significantly lower among those in the same-day discharge group compared with the overnight stay group. Larger prospective studies are warranted to confirm these findings, advised the investigators in Catheterization and Cardiovascular Interventions.
advertisement
Featured Video
Hear the full IMPERIAL Trial presentation from the Principal Investigator, William Gray, MD.
Sponsored by Boston Scientific
Related Articles
Top 5 Articles From March 2018
What Constitutes a Compromised Aortic Neck in 2018?
Anatomic risk factors associated with an increased risk of proximal seal failure with standard EVAR in the era of device and technique advancement.
By Graeme McFarland, MD; and Jason T. Lee, MD
The Ovation Abdominal Stent Graft Creates a Patient-Specific EVAR Seal in a Variety of Anatomies
With Salem M. George Jr, MD, FACS; Venkatesh Ramaiah, MD, FACS; and Matt Thompson, MD, FRCS
Abdominal Aortic Approaches
By Daniel G. Clair, MD; and Timothy A. Resch, MD, PhD
Nonfenestrated Options for Treating Compromised AAA Necks
How to overcome juxtarenal AAAs.
By Cornelis G. Vos, MD, PhD; Richte C.L. Schuurmann, MSc; and Jean-Paul P.M. de Vries, MD, PhD
Ask the Experts: Does Treating Type II Endoleak and the Aneurysm Sac Make a Difference?
With Naiem Nassiri, MD, RPVI; Alan Dardik, MD, PhD; Hence J.M. Verhagen, MD, PhD; Stéphan Haulon, MD, PhD; Claire Watkins, MD; Dominique Fabre, MD; and Gustavo S. Oderich, MD
Top 5 from CIToday's Current Issue
CT Assessment Before TMVR
By Moderator: Dee Dee Wang, MD, FACC, FASE, FSCCT
Panel: Mayra Guerrero, MD; and Marco Barbanti, MD
Challenging Cases: What Would You Do?
By Ted E. Feldman, MD, MSCAI, FACC, FESC; and Shakeel A. Qureshi, MD, FRCP, FRCPCH
Complicated Radial Access During Primary PCI
By Moderator: Pieter C. Smits, MD, PhD, FESC
Panel: Mohamed Abdel-Wahab, MD, FESC; Peter W. Danse, MD; and Valeria Paradies, MD
Peripheral Vascular Programs Could Improve Population Health and Grow Volumes
An overview of the steps involved in developing a PAD program to address this underserved patient population.
